Established in 1989, Amman Pharmaceutical Industries (API) was one of
the first pharmaceutical companies in the MENA region to pioneer the production
of niche branded generics in the therapeutic areas of Ophthalmology, ENT,
Respiratory, and Dermatology, and continues to be the leading regional
Until 2007, API concentrated on the markets for sterile eye drops and
ointments. In the decade since, API has expanded into new product lines in
Ophthalmology, Nasals, Orals, and Dermatology. API was also the first to
introduce nasal metered dose sprays to the local market, and is still one of
the few companies manufacturing nasal metered dose sprays in the region today.
API’s reach extends far beyond the Middle East, with 29 export markets that
include the European Economic Area, Ethiopia, and Azerbaijan and plans to
introduce more markets in the coming year.